Carotech wins patent on vitamin E complex

- Last updated on GMT

Related tags: Tocotrienol, Vitamin e

US-based Carotech has received a patent for a novel tocotrienol
complex, said to increase the bioavailability of tocotrienols in
the gastrointestinal tract.

The company, promoting the Tocomin Suprabio ingredient at Health Ingredients Europe​ next week, says a two-period, two-sequence crossover human bioavailability study has demonstrated that the tocotrienol is 200-300 per cent more bioavailable compared to the conventional tocotrienol oil extract.

This increase in absorption allows formulators to use a lower dosage to achieve the required therapeutic level in the bloodstream.

Tocotrienol is a form of natural vitamin E found in palm oil. There are significant differences between its chemical structure and that of tocopherol, another member of the vitamin E family, which is much more commonly used.

Previous research on Tocomin has determined that tocotrienols cross the blood-brain barrier and are potent protectors of neuron cells that may be killed due to stroke and other neurodegenerative diseases.

Carotech​ claims to be the biggest supplier of natural full spectrum palm tocotrienol complex in the world. It also produces the natural mixed carotene complex Caromin and non-GM phytosterols from palm fruits (Elaeis guineensis) under the Steromax brand.

Related topics: Regulation

Related news

Show more

Follow us

Featured Events

View more

Products

View more

Webinars